OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION
Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 1
Abstract
Omalizumab is a monoclonal antibody against immunoglobulin E (IgE) which prevents free IgE from interacting with the high and low affinity IgE receptors on effector cells. Results of various studies proved that omalizumab improves asthma control, reduces exacerbations, corticosteroids use and have the potential to reduce airway remodeling. Moreover, effectiveness of omalizumab is similar in high and low eosinophil subgroups. The clinical efficacy and safety of omalizumab are documented in many clinical trials.
Authors and Affiliations
DeimantÄ— Hoppenot
THE ROLE OF FIBROBLAST IN DEVELOPMENT OF AIRWAY REMODELING IN ASTHMA
Airway remodeling is an important component of the structural changes of airways seen in asthma. Fibroblasts are mesenchymal stem cells found in organism at non-contractile fibroblasts form or at contractility properti...
INHALED TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: TRIBUTE CLINICAL STUDY DATA
Chronic obstructive pulmonary disease (COPD) is characterised by persistent respiratory symptoms and airflow limitation. Due to disease severity, exacerbations, exacerbations, affecting the quality of life,...
Eosinophil induced airway smooth muscle remodelling in asthma
Characteristics of the studied subjects: A total of 39 nonsmoking adults participated in the study (22 steroid-free patients with intermittent or mild-to moderate persistent asthma, and 17 healthy participants who consti...
LITHUANIAN RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA
These recommendations establish clinical practice guidelines for the diagnosis and treatment of adult and children obstructive sleep apnea.
FACTORS ASSOCIATED WITH OUTCOMES OF DRUGRESISTANT TUBERCULOSIS
Objective. To determine factors associated with treatment outcomes among DR-TB (drug-resistant tuberculosis). Methodology. The study included 64 patients who were treated for pulmonary DR-TB in the hospital...